Advertisement
Screener

REGEN BIOPHARMA, INC. (RGBP) Scorecard

2.8 / 5 stars · 68/120 Roast Me

REGEN BIOPHARMA, INC. (RGBP) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
23/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseRGBP / S&P
-71.43% / 15.20%
LoseRGBP / S&P
0.00% / 15.00%
LoseRGBP / S&P
-85.00% / 50.40%
2026-Q10/3 LoseRGBP / S&P
-90.54% / -4.33%
LoseRGBP / S&P
0.00% / 11.30%
LoseRGBP / S&P
-81.82% / 27.70%
2025-Q40/3 LoseRGBP / S&P
-45.19% / 2.65%
LoseRGBP / S&P
0.00% / 9.00%
LoseRGBP / S&P
-84.00% / 13.40%
2025-Q30/3 LoseRGBP / S&P
-73.00% / 8.12%
LoseRGBP / S&P
0.00% / 4.61%
LoseRGBP / S&P
0.00% / 13.45%
2025-Q20/3 LoseRGBP / S&P
0.00% / 10.94%
LoseRGBP / S&P
-25.80% / 4.83%
LoseRGBP / S&P
-0.00% / 10.63%
2025-Q10/3 LoseRGBP / S&P
-28.88% / -4.27%
LoseRGBP / S&P
-18.82% / 4.98%
LoseRGBP / S&P
10.00% / 10.57%
2024-Q40/3 LoseRGBP / S&P
-31.55% / 2.41%
LoseRGBP / S&P
-10.39% / 5.25%
LoseRGBP / S&P
RGBP unavailable / 6.15%
2024-Q30/3 LoseRGBP / S&P
-68.22% / 5.89%
LoseRGBP / S&P
0.00% / 5.89%
LoseRGBP / S&P
RGBP unavailable / 6.11%
2024-Q21/3 LoseRGBP / S&P
-13.81% / 4.28%
WinRGBP / S&P
151.92% / 5.38%
LoseRGBP / S&P
RGBP unavailable / 5.12%
2024-Q11/3 LoseRGBP / S&P
-21.05% / 10.56%
WinRGBP / S&P
130.89% / 5.71%
LoseRGBP / S&P
RGBP unavailable / 5.59%
2023-Q41/3 LoseRGBP / S&P
-47.37% / 11.69%
WinRGBP / S&P
110.32% / 6.81%
LoseRGBP / S&P
RGBP unavailable / 7.78%
2023-Q31/3 LoseRGBP / S&P
-5.00% / -3.27%
WinRGBP / S&P
88.47% / 7.52%
LoseRGBP / S&P
RGBP unavailable / -5.03%
2023-Q20/3 LoseRGBP / S&P
-2.56% / 8.74%
LoseRGBP / S&P
0.55% / 9.50%
LoseRGBP / S&P
RGBP unavailable / -8.57%
2023-Q10/3 LoseRGBP / S&P
-66.67% / 7.50%
LoseRGBP / S&P
1.97% / 10.77%
LoseRGBP / S&P
RGBP unavailable / -15.69%
2022-Q40/3 LoseRGBP / S&P
-40.00% / 7.56%
LoseRGBP / S&P
4.37% / 11.88%
LoseRGBP / S&P
RGBP unavailable / -17.99%
2022-Q31/3 WinRGBP / S&P
41.30% / -4.88%
LoseRGBP / S&P
8.16% / 13.47%
LoseRGBP / S&P
RGBP unavailable / -1.41%
2022-Q20/3 LoseRGBP / S&P
-24.59% / -16.10%
LoseRGBP / S&P
12.60% / 13.71%
LoseRGBP / S&P
RGBP unavailable / 11.04%
2022-Q10/3 LoseRGBP / S&P
-58.36% / -4.60%
LoseRGBP / S&P
12.53% / 15.97%
LoseRGBP / S&P
RGBP unavailable / 42.23%
2021-Q40/3 LoseRGBP / S&P
-51.86% / 11.03%
LoseRGBP / S&P
9.33% / 15.00%
LoseRGBP / S&P
RGBP unavailable / 96.40%
2021-Q31/3 WinRGBP / S&P
101.52% / 0.58%
LoseRGBP / S&P
5.49% / 10.77%
LoseRGBP / S&P
RGBP unavailable / 69.42%
2021-Q21/3 WinRGBP / S&P
439.29% / 8.55%
LoseRGBP / S&P
1.62% / 6.58%
LoseRGBP / S&P
RGBP unavailable / 51.81%
2021-Q12/3 WinRGBP / S&P
180.00% / 6.17%
WinRGBP / S&P
0.00% / -1.06%
LoseRGBP / S&P
RGBP unavailable / 7.39%
2020-Q42/3 WinRGBP / S&P
233.33% / 12.15%
WinRGBP / S&P
0.00% / -3.72%
LoseRGBP / S&P
RGBP unavailable / -33.42%
2020-Q32/3 WinRGBP / S&P
50.00% / 8.93%
WinRGBP / S&P
0.00% / -2.04%
LoseRGBP / S&P
RGBP unavailable / -27.10%
2020-Q22/3 WinRGBP / S&P
100.00% / 20.54%
WinRGBP / S&P
33.70% / -0.46%
LoseRGBP / S&P
RGBP unavailable / -27.11%
2020-Q10/3 LoseRGBP / S&P
-50.00% / -19.60%
LoseRGBP / S&P
-28.96% / 3.47%
LoseRGBP / S&P
RGBP unavailable / -14.75%
2019-Q40/3 LoseRGBP / S&P
-81.82% / 9.07%
LoseRGBP / S&P
-13.67% / 5.36%
LoseRGBP / S&P
RGBP unavailable / 2.99%
2019-Q32/3 WinRGBP / S&P
37.50% / 1.70%
WinRGBP / S&P
10.00% / 5.02%
LoseRGBP / S&P
RGBP unavailable / 0.21%
2019-Q20/3 LoseRGBP / S&P
-42.86% / 4.30%
LoseRGBP / S&P
-17.73% / 6.64%
LoseRGBP / S&P
RGBP unavailable / 8.65%
2019-Q11/3 LoseRGBP / S&P
-50.00% / 13.65%
WinRGBP / S&P
40.77% / 8.12%
LoseRGBP / S&P
RGBP unavailable / 14.29%
2018-Q41/3 LoseRGBP / S&P
-76.27% / -13.52%
WinRGBP / S&P
15.84% / 9.05%
LoseRGBP / S&P
RGBP unavailable / 18.23%
2018-Q30/3 LoseRGBP / S&P
-48.70% / 7.71%
LoseRGBP / S&P
-9.09% / 10.21%
LoseRGBP / S&P
RGBP unavailable / 19.06%
2018-Q20/3 LoseRGBP / S&P
-33.91% / 3.43%
LoseRGBP / S&P
-52.38% / 9.03%
LoseRGBP / S&P
RGBP unavailable / 14.46%
2018-Q11/3 LoseRGBP / S&P
-31.76% / -0.76%
WinRGBP / S&P
10.00% / 7.68%
LoseRGBP / S&P
RGBP unavailable / 12.46%
2017-Q41/3 WinRGBP / S&P
8.74% / 6.64%
LoseRGBP / S&P
RGBP unavailable / 7.03%
LoseRGBP / S&P
RGBP unavailable / 13.82%
2017-Q31/3 WinRGBP / S&P
6.59% / 4.48%
LoseRGBP / S&P
RGBP unavailable / 5.68%
LoseRGBP / S&P
RGBP unavailable / 17.57%
2017-Q20/3 LoseRGBP / S&P
-15.38% / 3.09%
LoseRGBP / S&P
RGBP unavailable / 4.83%
LoseRGBP / S&P
RGBP unavailable / 17.74%
2017-Q10/3 LoseRGBP / S&P
-36.62% / 6.07%
LoseRGBP / S&P
RGBP unavailable / 3.67%
LoseRGBP / S&P
RGBP unavailable / 13.32%
2016-Q40/3 LoseRGBP / S&P
-34.36% / 3.82%
LoseRGBP / S&P
RGBP unavailable / 2.09%
LoseRGBP / S&P
RGBP unavailable / 7.05%
2016-Q31/3 WinRGBP / S&P
13.64% / 3.85%
LoseRGBP / S&P
RGBP unavailable / 0.20%
LoseRGBP / S&P
RGBP unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-28

MetricRGBP total returnS&P 500 Total Return Index
Total return-98.97%20.78%
Annualized return-98.97%20.78%

5Y · 2021-09-01 to 2026-08-28

MetricRGBP total returnS&P 500 Total Return Index
Total return-100.00%83.14%
Annualized return-91.22%12.86%

10Y · 2016-09-01 to 2026-08-28

MetricRGBP total returnS&P 500 Total Return Index
Total return-100.00%319.30%
Annualized return-72.95%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.